Osiris Therapeutics, Inc. , the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today its results for the first quarter of 2013.
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130507006042&newsLang=en&ndmConfigId=1000639&vnsId=41
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130507006042&newsLang=en&ndmConfigId=1000639&vnsId=41
No comments:
Post a Comment